Advancing the Use of GLP-1s in Neurodegenerative Disease - GLP-1-Based Therapeutics Summit

Skip to content

April 29 - May 1, Boston MA

LIMITED TICKETS AVAILBLE!

Home
About
Program
Partner
Take Part
- Register
- Get in Touch

Advancing the Use of GLP-1s in Neurodegenerative Disease

Time: 3:10 pm
day: Day Two

Speakers:

Adam Bell

VENUE

Wyndham Boston Beacon Hill
5 Blossom St, Boston, MA 02114

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
[email protected]

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Searchlight	Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok